| Date Filed | Type | Description |
| 09/29/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
| 08/15/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 08/14/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/10/2023 |
8-K
| Quarterly results |
| 07/21/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 07/21/2023 |
8-K
| Quarterly results |
| 07/12/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 06/30/2023 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 06/07/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 06/07/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 05/15/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/15/2023 |
8-K
| Quarterly results |
| 05/09/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 05/01/2023 |
10-K/A
| Annual Report for the period ended December 31, 2022 [amend] |
| 03/16/2023 |
8-K
| Quarterly results |
| 02/13/2023 |
8-K
| Quarterly results |
| 12/19/2022 |
8-K
| Quarterly results |
| 11/15/2022 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 11/14/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 11/14/2022 |
8-K
| Quarterly results |
| 08/18/2022 |
8-K
| Quarterly results |
| 08/15/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 08/11/2022 |
8-K
| Quarterly results |
| 07/21/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 07/21/2022 |
8-K
| Quarterly results |
| 06/13/2022 |
8-K
| Quarterly results |
| 05/25/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 05/13/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
| 05/11/2022 |
8-K
| Quarterly results |
| 04/29/2022 |
10-K/A
| Annual Report for the period ended December 31, 2021 [amend] |
| 03/21/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
| 03/17/2022 |
8-K
| Quarterly results |
| 02/14/2022 |
SC 13G/A
| CVI Investments, Inc. reports a 0% stake in Onconova Therapeutics, Inc. |
| 02/09/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
|